Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway

被引:260
作者
Kim, I
Kim, JH
Moon, SO
Kwak, HJ
Kim, NG
Koh, GY
机构
[1] Chonbuk Univ, Sch Med, Natl Creat Res Initiat Ctr Cardiac Regenerat, Chonju 560180, South Korea
[2] Chonbuk Univ, Sch Med, Cardiovasc Res Inst, Chonju 560180, South Korea
[3] Chonbuk Univ, Sch Med, Dept Biomed Engn, Chonju 560180, South Korea
关键词
angiopoietin-2; endothelial cells; apoptosis; PI 3 '-kinase; Akt;
D O I
10.1038/sj.onc.1203800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The angiopoietin-Tie2 system in endothelial cells is an important regulator of vasculogenesis and vascular integrity, High levels of angiopoietin-2 (Ang2) mRNA are observed in vascular activation during tumorigenesis. Although Ang2 is known to be a naturally occurring antagonist of angiopoietin-1 (Ang1) in vivo, the exact function of Ang2 itself is not known. Here, we found that a high concentration of Ang2 (800 ng/ml) acts as an apoptosis survival factor for endothelial cells during serum deprivation apoptosis, The survival effect of high concentration Ang2 was blocked by pre-treatment with soluble Tie2 receptor and the PI 3'-kinase-specific inhibitors, wortmannin and LY294002. Accordingly, 800 ng/ml of Ang2 induced phosphorylation of Tie2, the p85 subunit of phosphatidylinositol 3'-kinase (PI 3'-kinase), and serine-threonine kinase Akt at Ser473 in the human umbilical vein endothelial cells; lower concentrations of Ang2 (50-400 ng/ml) did not produce notable effects. These findings indicate that at high concentrations, Ang2, like Ang1, can be an apoptosis survival factor for endothelial cells through the activation of the Tie2 receptor, PI 3'-kinase and Akt, and thus may be a positive regulator of tumor angiogenesis.
引用
收藏
页码:4549 / 4552
页数:4
相关论文
共 28 条
[1]   Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization [J].
Asahara, T ;
Chen, DH ;
Takahashi, T ;
Fujikawa, K ;
Kearney, M ;
Magner, M ;
Yancopoulos, GD ;
Isner, JM .
CIRCULATION RESEARCH, 1998, 83 (03) :233-240
[2]   Regulation of cell death protease caspase-9 by phosphorylation [J].
Cardone, MH ;
Roy, N ;
Stennicke, HR ;
Salvesen, GS ;
Franke, TF ;
Stanbridge, E ;
Frisch, S ;
Reed, JC .
SCIENCE, 1998, 282 (5392) :1318-1321
[3]   Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[4]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[5]   Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development [J].
Dunk, C ;
Shams, M ;
Nijjar, S ;
Rhaman, M ;
Qiu, Y ;
Bussolati, B ;
Ahmed, A .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06) :2185-2199
[6]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364
[7]   Signaling vascular morphogenesis and maintenance [J].
Hanahan, D .
SCIENCE, 1997, 277 (5322) :48-50
[8]   Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J].
Holash, J ;
Maisonpierre, PC ;
Compton, D ;
Boland, P ;
Alexander, CR ;
Zagzag, D ;
Yancopoulos, GD ;
Wiegand, SJ .
SCIENCE, 1999, 284 (5422) :1994-1998
[9]   Characterization and expression of a novel alternatively spliced human angiopoietin-2 [J].
Kim, I ;
Kim, JH ;
Ryu, YS ;
Jung, SH ;
Nah, JJ ;
Koh, GY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18550-18556
[10]   Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway [J].
Kim, I ;
Kim, HG ;
So, JN ;
Kim, JH ;
Kwak, HJ ;
Koh, GY .
CIRCULATION RESEARCH, 2000, 86 (01) :24-29